Get the Stockscreener App
9.41
3.39%
-0.33
After Hours:
9.42
0.010
+0.11%
Dynavax Technologies Corp stock is traded at $9.41, with a volume of 1.65M.
It is down -3.39% in the last 24 hours and down -11.06% over the past month.
Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.
See More
Previous Close:
$9.74
Open:
$9.67
24h Volume:
1.65M
Relative Volume:
0.98
Market Cap:
$1.10B
Revenue:
$260.81M
Net Income/Loss:
$20.48M
P/E Ratio:
72.38
EPS:
0.13
Net Cash Flow:
$22.67M
1W Performance:
-6.46%
1M Performance:
-11.06%
6M Performance:
-31.51%
1Y Performance:
-14.22%
1-Day Range:
$9.40
$9.67
1-Week Range:
$9.40
$10.03
52-Week Range:
$9.22
$14.63
Dynavax Technologies Corp Stock (DVAX) Company Profile
Name
Dynavax Technologies Corp
Sector
Phone
(510) 848-5100
Address
2100 POWELL STREET, EMERYVILLE, CA
Compare DVAX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DVAX
Dynavax Technologies Corp
|
9.41 | 1.14B | 260.81M | 20.48M | 22.67M | 0.13 |
|
ZTS
Zoetis Inc
|
148.20 | 66.22B | 9.39B | 2.62B | 2.22B | 5.81 |
|
TAK
Takeda Pharmaceutical Co Adr
|
15.10 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
|
HLN
Haleon Plc Adr
|
9.81 | 43.99B | 14.26B | 1.98B | 2.47B | 0.4347 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
19.93 | 22.45B | 16.70B | -157.13M | 1.19B | -0.155 |
|
UTHR
United Therapeutics Corp
|
405.02 | 17.93B | 2.99B | 1.21B | 1.13B | 25.06 |
Dynavax Technologies Corp Stock (DVAX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-11-25 | Downgrade | Goldman | Neutral → Sell |
| Feb-01-24 | Initiated | Goldman | Neutral |
| Sep-27-22 | Initiated | JMP Securities | Mkt Outperform |
| Jan-06-22 | Resumed | Goldman | Buy |
| Aug-06-21 | Initiated | Goldman | Buy |
| Aug-07-20 | Reiterated | H.C. Wainwright | Buy |
| Aug-03-20 | Reiterated | H.C. Wainwright | Buy |
| Jun-15-20 | Initiated | Evercore ISI | Outperform |
| Oct-18-19 | Initiated | H.C. Wainwright | Buy |
| Jul-11-19 | Upgrade | Cantor Fitzgerald | Neutral → Overweight |
| Feb-27-19 | Reiterated | Cantor Fitzgerald | Overweight |
| May-10-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Mar-08-18 | Reiterated | Cantor Fitzgerald | Overweight |
| Feb-14-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Sep-25-17 | Reiterated | RBC Capital Mkts | Outperform |
| Sep-15-17 | Initiated | Cantor Fitzgerald | Overweight |
| Jul-31-17 | Upgrade | JP Morgan | Neutral → Overweight |
| Jul-31-17 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| May-09-17 | Reiterated | RBC Capital Mkts | Sector Perform |
| Apr-28-16 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Apr-27-16 | Downgrade | JP Morgan | Overweight → Neutral |
| Nov-30-15 | Initiated | RBC Capital Mkts | Outperform |
| Nov-25-13 | Upgrade | MLV & Co | Hold → Buy |
| Feb-25-13 | Downgrade | MLV & Co | Buy → Hold |
| Nov-16-12 | Reiterated | MLV & Co | Buy |
View All
Dynavax Technologies Corp Stock (DVAX) Latest News
What to do if you’re stuck in Dynavax Technologies Corporation2025 Earnings Surprises & AI Powered Buy and Sell Recommendations - Newser
Sentiment analysis tools applied to Dynavax Technologies CorporationQuarterly Risk Review & AI Based Buy and Sell Signals - Newser
Published on: 2025-09-12 19:29:54 - Newser
Is this a good reentry point in Dynavax Technologies CorporationWeekly Stock Report & High Yield Stock Recommendations - Newser
Analyzing Dynavax Technologies Corporation with risk reward ratio chartsQuarterly Profit Summary & Daily Market Momentum Tracking - Newser
Visualizing Dynavax Technologies Corporation stock with heatmapsJuly 2025 Spike Watch & Capital Protection Trading Alerts - Newser
Should you hold or exit Dynavax Technologies Corporation nowMarket Activity Report & Real-Time Volume Spike Alerts - Newser
Dynavax Technologies Corporation stock trendline breakdownPortfolio Performance Report & Low Drawdown Investment Strategies - Newser
Price action breakdown for Dynavax Technologies CorporationEntry Point & Long-Term Safe Return Strategies - Newser
Short interest data insights for Dynavax Technologies CorporationJuly 2025 PostEarnings & Verified Chart Pattern Signals - Newser
What’s next for Dynavax Technologies Corporation stock priceEarnings Performance Report & Capital Efficiency Focused Ideas - Newser
Trend analysis for Dynavax Technologies Corporation this weekMarket Trend Summary & Real-Time Market Sentiment Reports - Newser
Order flow analysis tools used on Dynavax Technologies CorporationMarket Rally & High Accuracy Trade Signal Alerts - Newser
Analyzing net buyer seller activity in Dynavax Technologies CorporationPortfolio Update Report & Weekly Setup with High ROI Potential - Newser
Forecasting Dynavax Technologies Corporation price range with options dataJuly 2025 Market Mood & Low Risk Investment Opportunities - Newser
Has Dynavax Technologies Corporation formed a bullish divergence2025 Institutional Moves & Breakout Confirmation Alerts - Newser
Intraday pattern recognizer results for Dynavax Technologies CorporationWeekly Earnings Recap & Real-Time Market Sentiment Alerts - Newser
How to use Fibonacci retracement on Dynavax Technologies CorporationLayoff News & Accurate Intraday Trading Signals - Newser
What earnings revisions data tells us about Dynavax Technologies CorporationQuarterly Portfolio Summary & Reliable Intraday Trade Plans - Newser
36,585 Shares in Dynavax Technologies Corporation $DVAX Acquired by Uniplan Investment Counsel Inc. - MarketBeat
Published on: 2025-09-10 04:45:10 - Newser
Dynavax Technologies Corporation stock prediction for this week2025 Risk Factors & Reliable Momentum Entry Alerts - Newser
Dynavax Technologies Corporation stock trend outlook and recovery pathVolume Spike & Community Verified Swing Trade Signals - Newser
Published on: 2025-09-09 22:59:24 - Newser
Historical volatility pattern of Dynavax Technologies Corporation visualizedEarnings Recap Report & AI Based Buy and Sell Signals - Newser
Published on: 2025-09-09 07:22:25 - Newser
Dynavax Technologies Corporation stock daily chart insightsQuarterly Trade Summary & Trade Opportunity Analysis Reports - Newser
what’s next for dynavax technologies corporation stock priceQuarterly Performance Summary & Precise Swing Trade Alerts - Newser
Applying sector rotation models to Dynavax Technologies CorporationGlobal Markets & Daily Price Action Insights - Newser
Can machine learning forecast Dynavax Technologies Corporation recoveryJuly 2025 Retail & Verified Short-Term Plans - Newser
Regression analysis insights on Dynavax Technologies Corporation performanceMarket Sentiment Summary & Free Weekly Chart Analysis and Trade Guides - Newser
Published on: 2025-09-08 05:06:25 - Newser
ADAR1 Capital Management LLC Acquires New Shares in Dynavax Technologies Corporation $DVAX - MarketBeat
Is now a turning point for Dynavax Technologies CorporationTrend Reversal & Accurate Entry/Exit Alerts - Newser
Analyzing Dynavax Technologies Corporation with multi timeframe chartsJuly 2025 Market Mood & High Return Trade Guides - Newser
Dynavax Technologies Corp Stock (DVAX) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.67%
0.04%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):